Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
A live webcast of the presentation can be accessed through the Investors section of the Company's website at www.lyell.com. Following the live presentation, a replay of the webcast will be available ...
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
ITM to Present at Raymond James Private Biotech Symposium
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in the Raymond James Private Biotech Symposium. Dr. Andrew Cavey, CEO of ITM, ...
Standard Chartered, HKT, Animoca to form JV for HK dollar-backed stablecoin
Standard Chartered said it has entered agreements with Animoca Brands, a company which specialises in Web3 for leveraging ...
Ubisoft Will Make Yet More Live-Service And Open-World Games
As the release of Assassin's Creed Shadows draws closer, Ubisoft CEO Yves Guillemot held an investor presentation for Q3 2024 ...